Boeing: Production ramp inflection turns years of pain into a multi-year earnings recovery

Stevie AI on Boeing Company (BA-USA | boeingcompan)

3/30/2026

Summary

Boeing is the world's second-largest commercial aircraft manufacturer and a top-tier defense contractor, operating across three segments — Boeing Commercial Airplanes (BCA), Boeing Defense, Space & Security (BDS), and Boeing Global Services (BGS) — with a combined backlog of $682B that represents nearly a decade of production at normalized rates. The structural insight is simple but powerful: Boeing is not a broken business, it is a temporarily impaired one. The 737 MAX grounding, COVID demand collapse, labor disruptions, and a cascade of fixed-price defense contract charges destroyed near-term profitability while leaving the order book and duopoly franchise entirely intact. With production rates now inflecting, MAX-7/10 certifications approaching, and 777X on track for 2027 first delivery, Boeing is entering a multi-year earnings recovery cycle that the market is only beginning to price. Recent financial performance reflects the depth of the trough. FY2024 saw revenue of just $20.0B and a net loss of $11.8B (EPS: -$18.36), as strike-related production stoppages, abnormal charges, and balance sheet stress converged simultaneously. FY2025 marked the first critical inflection: revenue grew modestly to $20.9B and net income turned positive at $2.2B (EPS: $2.48), validating that the operational restructuring and delivery ramp are beginning to translate into financials. BCA's record $567B backlog — representing roughly 5,600+ aircraft — underscores that demand destruction was never the problem; supply and execution were. We initiate with a BUY rating and a base-case price target of $196 in 2026, rising to $275 by 2027 and $391 by 2028 on our forecasts. We apply a 35x forward P/E multiple to Boeing's normalized earnings, reflecting the company's position in a capital-intensive, high-barrier-to-entry duopoly with a decade-long revenue backlog, significant FCF inflection ahead, and a compressing but still-elevated net debt load. Aerospace recovery plays with visible multi-year earnings ramps — particularly those emerging from cyclical or operational troughs — historically command premium multiples as the market prices earnings normalization 2-3 years forward. At $190.52, Boeing trades at just 77x our FY2025 actual EPS of $2.48, but only 37x our FY2026 EPS of $2.47 and a compelling 18x our FY2028 EPS of $7.82, making the forward earnings curve the central investment argument.

Thesis

1. **Duopoly franchise with $682B backlog provides decade-long revenue visibility** Boeing and Airbus constitute one of the most structurally protected duopolies in global industry. Certifying a new commercial aircraft program requires 10-15 years and tens of billions in capital investment — a barrier no credible new entrant has cleared in the narrowbody or widebody segments. COMAC's C919 remains confined to domestic Chinese operations with limited certification progress in Western markets, and Embraer operates in a distinct regional jet category. This duopoly structure means Boeing does not compete on price discovery in a commodity market; it competes on delivery slots, financing terms, and service relationships across a captive installed base of 10,000+ aircraft. BCA's $567B commercial backlog alone — supplemented by BDS's $85B defense backlog and BGS's $30B services backlog — provides an extraordinary degree of forward revenue visibility that most industrial companies cannot claim. At our forecast FY2029 revenue run-rate of $57.4B, the total $682B backlog represents approximately 12 years of current-period revenue. This is not a company searching for demand; it is a company racing to fulfill orders it already holds. The strategic implication for investors is that revenue growth through 2029 is largely pre-sold — execution risk, not demand risk, is the variable being priced. The competitive moat extends into aftermarket services via BGS, which generated $5.2B in quarterly revenue. As the installed base of Boeing aircraft grows with the delivery ramp, BGS's addressable market expands structurally, providing a higher-margin, more recurring revenue stream that partially offsets the lumpiness of OEM aircraft deliveries. BGS's $30B backlog and relatively stable margin profile make it an underappreciated earnings quality anchor within the consolidated financials. 2. **737 MAX production ramp is the single biggest near-term earnings driver** The 737 MAX program is Boeing's profit engine, accounting for the majority of BCA revenue and the bulk of near-term earnings upside. In 2025, Boeing delivered 447 737s — a number severely constrained by prior-year strike disruptions and supply chain normalization. Management has guided to approximately 500 737 deliveries in 2026, with production targeting 47 aircraft per month — a ~12% unit volume increase that drops disproportionately to operating income given the high fixed-cost nature of aircraft manufacturing. The MAX-7 and MAX-10 certification represents a discrete, near-term catalyst with quantifiable financial impact. Approximately 35 aircraft in inventory are awaiting delivery pending FAA approval of engine anti-ice design changes. Certification in 2026 would unlock these deliveries, contributing an estimated $2-3B in incremental revenue recognition and meaningfully improving FY2026 FCF versus the downside scenario. Beyond the inventory release, MAX-10 certification is critical because the -10 variant commands higher list prices and targets the high-density domestic routes where Airbus's A321neo has been gaining share — Boeing cannot fully compete for that demand without an FAA-approved product. By 2029, our model projects ~580 737 deliveries annually. Applying industry estimates of ~$50-55M average selling price per MAX unit, the narrowbody program alone would generate approximately $28-32B in annual revenue — a figure that contextualizes why gross margin expansion from ~20% in 2025 toward ~28% by 2029 is credible as fixed-cost absorption improves with volume. Every incremental delivery at the margin carries significantly higher contribution than the average, making the ramp's linearity critically important to watch. 3. **787 and 777X widen the recovery from narrowbody to full portfolio** While the 737 ramp drives near-term recovery, the widebody portfolio — 787 Dreamliner and 777X — represents the medium-term margin and revenue expansion story. The 787 program has stabilized production at 8 aircraft per month following years of quality remediation and FAA-mandated production pauses. Management targets a move toward 10/month by 2028, which would yield 100-120 annual deliveries versus 88 in 2025. At an average selling price of approximately $250-280M per 787, this production increase alone represents $3-5B in incremental annual revenue. The 777X program is perhaps the most important long-duration catalyst in Boeing's portfolio. First delivery of the 777-9 is targeted for 2027, opening an entirely new widebody revenue stream at the premium end of the market. The 777-9 competes directly against Airbus's A350-1000 in the ultra-long-haul, high-capacity segment favored by Gulf carriers and Asian long-haul operators. With a list price exceeding $400M per aircraft and significant GE9X engine aftermarket value accruing to Boeing's ecosystem, the 777X represents both a revenue diversification event and a proof point that Boeing can successfully execute a next-generation program — a confidence signal the market has been skeptical about since the MAX grounding. Together, the 787 ramp and 777X entry into service should push BCA revenue from approximately $11.4B quarterly in late 2025 toward materially higher run-rates by 2028-2029, supporting our forecast of $50.4B in total FY2028 revenue — nearly 2.5x the FY2024 revenue trough. 4. **Gross margin expansion from 20% to 28% is structurally grounded, not aspirational** Boeing's path from ~20% gross margins in 2025 toward ~28% by 2029 is not a management aspiration — it is a mathematically predictable outcome of three converging dynamics: fixed-cost absorption, deferred production cost burn-down, and the elimination of abnormal/reach-forward loss charges. First, commercial aircraft manufacturing is intensely fixed-cost-heavy. Factory overhead, tooling amortization, engineering labor, and regulatory compliance costs are largely invariant to delivery volume in the near term. As Boeing moves from ~550 total deliveries in 2026 toward 600+ by 2029, each incremental unit carries a materially lower per-unit overhead burden — a classic operating leverage effect that has historically driven substantial margin recovery for Airbus during its prior production ramp cycles. Second, Boeing's 787 program carried significant deferred production costs from the years of production disruption and below-standard rate operations. As production stabilizes at higher rates and the deferred cost pool begins to amortize against greater unit volume, accounting drag on program margins diminishes. Third, and most structurally significant, the BDS fixed-price contract headwinds — which generated hundreds of millions in quarterly charges on programs like KC-46, T-7A, and MQ-25 — are expected to moderate as loss-making contracts approach completion milestones or are re-priced. While BDS margin recovery will be gradual, the elimination of outsized abnormal charges is a margin tailwind requiring no incremental execution, only the passage of time. The net income trajectory from $2.2B in FY2025 to $8.4B in FY2029 — a nearly 4x increase over four years — is the financial expression of this margin expansion thesis, and it occurs even as revenue roughly triples from the FY2024 trough, creating a powerful combined top-line and margin leverage story. 5. **FCF inflection and debt reduction remove the balance sheet overhang** Boeing's balance sheet is the most legitimate structural concern for investors, with net debt of approximately $45.2B forecast at end of FY2026 and gross debt near $54B. Interest expense on this debt load represents a meaningful drag on net income that depresses reported EPS relative to operating earnings quality. However, the trajectory matters more than the absolute level at this stage of recovery. Our forecast shows FCF inflecting from $0.4B in FY2026 to $3.3B in FY2027, $6.4B in FY2028, and $9.6B in FY2029 — a compounding FCF ramp driven by delivery volume growth, working capital normalization, and declining capex intensity as production infrastructure investments mature. Critically, net debt declines from $45.2B in FY2026 to $36.7B by FY2029, representing approximately $8-10B of balance sheet repair funded entirely by operations. As the debt load decreases, the interest burden lightens, creating a virtuous cycle where lower interest expense drives higher net income, which in turn supports further debt reduction. Capital allocation priorities are appropriately sequenced: debt reduction first through 2027, followed by modest capex investment, with buybacks becoming meaningful only in 2028-2029 when FCF generation is sufficiently robust. This discipline — if maintained — avoids the risk of premature capital return that could stress liquidity during production ramp volatility. For long-duration equity investors, the 2028-2029 FCF yield at current prices ($6.4-9.6B FCF against a ~$120B market cap) is a compelling entry point argument: a ~5-8% FCF yield on a structurally growing business in a protected duopoly represents significant value. 6. **Market mispricing: consensus is anchoring to trough history, not forward normalization** Boeing's current valuation of $190.52 reflects a market that remains deeply anchored to the operational failures of 2019-2024, treating each production setback and certification delay as evidence of permanent impairment rather than recoverable execution risk. This behavioral anchoring creates the mispricing opportunity. At 77x FY2025 actual EPS of $2.48, the stock appears expensive in trailing terms — but this metric is analytically irrelevant for a company in the first year of a multi-year earnings recovery. The correct lens is forward normalization. At 37x our FY2026 EPS forecast of $2.47, Boeing still appears optically expensive — but FY2026 EPS is itself heavily suppressed by ~$2.5B in annual interest expense on the gross debt load and by production ramp costs that have not yet generated their full unit-volume economics. By FY2028, at $7.82 EPS, Boeing trades at just 24x — below the S&P 500 average — despite being a near-monopoly supplier in a market where demand growth is structurally driven by global aviation traffic, fleet renewal cycles, and emerging market middle-class expansion. By FY2029, at $10.60 EPS, the implied P/E drops to approximately 18x, representing a material discount to the market multiple for a business with a $682B backlog and decade-long revenue visibility. The asymmetry is compelling: the downside case is largely a timing story (certification delays, delivery pushouts) rather than a demand destruction story, and the upside case — a business generating $9-10B in annual FCF by 2029 — is not yet reflected in consensus estimates or market pricing. We believe investors who can tolerate near-term execution volatility are being paid to own one of the world's most structurally protected businesses at a recovery-trough valuation.

Risks

1. **FAA Certification Delays for 737-7 and 737-10** The most proximate and quantifiable risk to our thesis is further delay in FAA certification of the 737 MAX-7 and MAX-10 variants. Certification depends on FAA approval of engine anti-ice design changes — a process that has already experienced multiple slippages and remains subject to regulatory discretion that Boeing cannot fully control. If certification slips into late 2026 or 2027, the ~35 stored aircraft awaiting delivery would not be recognized as revenue in FY2026, reducing our revenue forecast by an estimated $2-3B and meaningfully impairing FCF generation in the year management has guided to $1-3B positive — a miss that would test investor confidence in management's recovery narrative. Beyond the inventory release, MAX-10 certification delay has a longer-duration impact: it constrains Boeing's ability to compete against Airbus's A321neo in the high-density domestic narrow-body segment, potentially ceding additional market share during Boeing's production ramp. In a duopoly where market share shifts are measured in decades, each year of MAX-10 absence from the certified market is a compounding competitive disadvantage. 2. **777X Program Risk: Engine Durability and First Delivery Slippage** The 777X program has been one of Boeing's most protracted development sagas, with first delivery having already slipped multiple years from original targets. Management has indicated the program remains on track for 2027, but a recently identified GE9X engine durability issue identified during inspection introduces fresh uncertainty. While Boeing stated no expected delivery impact, the root cause and corrective action timeline with GE Aerospace remain unresolved — and historical precedent on this program suggests that 'no expected impact' statements have not always proven reliable. A 777X first delivery slip into 2028 would have material financial consequences: it would delay the opening of a premium-priced widebody revenue stream, extend the cash consumption phase of the program, and — most importantly — signal continued execution fragility to a market that has already significantly discounted Boeing's program management credibility. The 777X is not just a revenue event; it is a proof-of-concept milestone for Boeing's ability to execute next-generation programs, and its on-time delivery is critical to restoring investor confidence in the longer-duration roadmap. 3. **Balance Sheet Fragility and Refinancing Risk** With gross debt near $54B and net debt of $45.2B projected through FY2026, Boeing's balance sheet leaves limited margin for error. Near-term FCF generation remains modest — our $0.4B FCF forecast for FY2026 provides negligible liquidity buffer against production disruptions, certification-related revenue delays, or unexpected cash charges. If FCF disappoints in 2026-2027, Boeing could face pressure to access capital markets at elevated rates, issue dilutive equity, or constrain investment in the production ramp itself — a doom loop scenario where balance sheet stress impairs the operational recovery that is needed to repair the balance sheet. The $2-3B in annual interest expense represents a persistent drag that keeps reported EPS materially below operating earnings quality through at least 2027. Any rise in benchmark interest rates or deterioration in Boeing's credit rating — currently sub-investment-grade at some agencies — could increase refinancing costs on maturing tranches, compressing the net income trajectory we have modeled. Investors should monitor gross debt maturity schedules and credit agency actions as leading indicators of balance sheet risk. 4. **BDS Fixed-Price Contract Losses and Defense Budget Uncertainty** Boeing Defense has been a persistent source of earnings volatility, generating billions in cumulative charges on fixed-price development programs including KC-46A Pegasus, T-7A Red Hawk, MQ-25 Stingray, and the VC-25B presidential aircraft replacement. While our forecast assumes BDS stabilizes around $24B revenue with selective margin recovery as loss-making contracts approach completion, there is no guarantee that existing programs will not require additional charges — particularly on programs with complex integration requirements and government specification changes. Beyond program-specific risk, the broader U.S. defense budget environment introduces macro-level uncertainty. Continuing resolutions, potential sequestration, and shifting DoD procurement priorities under evolving administrations could affect both the volume and timing of BDS contract awards. BDS's $85B backlog provides some insulation, but a sustained reduction in defense spending growth would pressure the segment's contribution to Boeing's consolidated recovery. We note that our forecast assigns BDS approximately $24B in stabilized revenue — any meaningful shortfall would require corresponding reductions in our consolidated revenue and margin trajectory. 5. **Labor Relations and Production Disruption Risk** Boeing's 2024 IAM machinist strike — which idled 737, 767, and 777 production for nearly two months and contributed materially to the FY2024 revenue and cash flow collapse — demonstrated the acute vulnerability of a production ramp recovery story to labor disruption. The new labor agreement provides near-term stability, but IAM and SPEEA contracts have historically been renegotiated on 4-year cycles, meaning the next negotiation window coincides with the critical 2027-2028 period when our model assumes peak production ramp execution. A work stoppage during the 777X first delivery window or peak 787/737 ramp would be disproportionately damaging relative to the strike's duration, as production rate recovery after a stoppage requires weeks-to-months of supply chain and workforce reactivation. Supply chain concentration risk amplifies this vulnerability — Boeing's narrowbody supply chain (Spirit AeroSystems fuselages, CFM LEAP-1B engines, key avionics suppliers) has demonstrated persistent capacity constraints, and any bottleneck in the supplier ecosystem during the ramp period would cascade into missed delivery targets and deferred revenue recognition. 6. **Execution Risk on Gross Margin Expansion Assumptions** Our $2029 price target of $371 is critically dependent on gross margin expansion from ~20% in 2025 to ~28% by 2029. While we believe this trajectory is structurally grounded in fixed-cost absorption, deferred production cost burn-down, and the cessation of abnormal charges, it represents an 800 basis point improvement over four years that requires near-flawless execution across multiple simultaneous programs. History suggests Boeing's actual margin delivery has consistently underperformed internal targets during production ramp phases, as quality escapes, rework, and supplier-driven variability inflate per-unit costs above plan. If gross margins expand to only ~24-25% by 2029 rather than our 28% forecast — a scenario consistent with modest execution friction rather than catastrophic failure — the impact on net income and EPS would be material. A 300bps gross margin shortfall on $57B of FY2029 revenue represents approximately $1.7B of foregone gross profit, which at a 25% tax rate would reduce FY2029 EPS by approximately $1.60/share, compressing our FY2029 price target by roughly $56 at our assumed 35x multiple. Investors should treat margin expansion assumptions as the single most important variable to track on a quarterly basis.

📈 Price Targets